Global Stomach Cancer Treatment Market worth USD 15.45 Billion by 2033 | CAGR of 12.47%
Category: HealthcareGlobal Stomach Cancer Treatment Market worth USD 15.45 Billion by 2033
According to a research report published by Spherical Insights & Consulting, the Global Stomach Cancer Treatment Market Size is Expected to Grow from USD 4.77 Billion in 2023 to USD 15.45 Billion by 2033, at a CAGR of 12.47% during the forecast period 2023-2033.
Get more details on this report -
Browse key industry insights spread across 236 pages with 110 Market data tables and figures & charts from the report on the" Global Stomach Cancer Treatment Market Size, Share, and COVID-19 Impact Analysis, By Treatment Type (Standard Chemotherapy, Targeted Therapy, and Immunotherapy), By Diseases Indication (Gastric Cancer/Gastroesophageal Junction Cancer and Gastrointestinal Stromal Tumors), By Route of Administration (Oral and Injectable), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/stomach-cancer-treatment-market
Stomach cancer, also known as gastric cancer, is one type of cancer that begins in the stomach lining. In nature, gastric neuroendocrine tumors (gNET) and gastrointestinal stromal tumors (GIST) are uncommon. The main causes of the growing number of cancer patients and the scarcity of first-line medications have prompted numerous pharmaceutical behemoths to undertake research to create new medications. The stomach's body is where stomach cancer typically starts. One of the leading causes of cancer-related mortality worldwide, gastric cancer ranks fifth in terms of incidence. The number of patients is growing as a result of the quick adoption of cutting-edge diagnostic techniques for the early detection of stomach cancer. The expansion of the stomach cancer medication market is expected to benefit from this. Growth is anticipated to be driven by the introduction of new medications and the growing use of immunotherapy and targeted therapy. Funding for stomach cancer research and treatment development, early detection programs, and government campaigns to raise cancer awareness are some of the primary factors driving the growth in the stomach cancer treatment market. However, the primary aspects that could restrict the stomach cancer therapeutics market are the high cost of the medications and the adverse consequences of the treatment.
The targeted therapy segment is predicted to hold the largest market share through the forecast period.
Based on the treatment type, the stomach cancer treatment market is classified into standard chemotherapy, targeted therapy, and immunotherapy. Among these, the targeted therapy segment is predicted to hold the largest market share through the forecast period. Interest in and uptake of targeted therapy among patients and healthcare professionals have been further stimulated by the emergence of personalized medicine and the discovery and approval of innovative targeted drugs.
The gastric cancer/gastroesophageal junction cancer segment is anticipated to hold the highest market share during the projected timeframe.
Based on the disease indication, the stomach cancer treatment market is divided into gastric cancer/gastroesophageal junction cancer and gastrointestinal stromal tumors. Among these, the gastric cancer/gastroesophageal junction cancer segment is anticipated to hold the highest market share during the projected timeframe. In clinical procedures for gastric cancer and gastroesophageal junction cancer, the complexity of these cancers which are frequently detected at advanced stages raises the focus on cutting-edge treatment choices and tailored medicines.
The injectable segment is anticipated to hold the highest market share during the projected timeframe.
Based on the route of administration, the stomach cancer treatment market is divided into oral, and injectable. Among these, the injectable segment is anticipated to hold the highest market share during the projected timeframe. The ability to deliver chemotherapy and targeted medicines straight into the bloodstream and their quick therapeutic action made injectable treatment possible.
Asia Pacific is estimated to hold the largest share of the stomach cancer treatment market over the forecast period.
Get more details on this report -
Asia Pacific is estimated to hold the largest share of the stomach cancer treatment market over the forecast period. The nation's healthcare reforms have made getting cutting-edge treatments like immunotherapy and targeted therapies easier. Patients have more therapy options due to continuing clinical studies and greater spending on cancer research.
Middle East & Africa is predicted to grow at the highest CAGR growth in the stomach cancer treatment market over the forecast period. The pharmaceutical companies' international collaborations and investments are expanding access to cutting-edge treatments, which are expected to improve patient care in this multicultural region.
Major key players in the stomach cancer treatment market include Samsung Bioepis, Novartis AG, Mylan N.V., F. Hoffmann-La Roche Ltd, Eli Lilly and Company, Merck & Co., Inc., CELLTRION INC., Teva Pharmaceutical Industries Ltd., Pfizer Inc., Bristol-Myers Squibb Company, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In January 2024, in advanced gastroenteropancreatic neuroendocrine tumors, Novartis announced that Lutathera considerably decreased the probability of disease progression or death by 72%, demonstrating the efficacy of radioligand therapy as a first-line treatment.
Market Segment
- This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the stomach cancer treatment market based on the below-mentioned segments:
Global Stomach Cancer Treatment Market, By Treatment Type
- Standard Chemotherapy
- Targeted Therapy
- Immunotherapy
Global Stomach Cancer Treatment Market, By Disease Indication
- Gastric Cancer/Gastroesophageal Junction cancer
- Gastrointestinal Stromal Tumors
Global Stomach Cancer Treatment Market, By Route of Administration
- Oral
- Injectable
Global Stomach Cancer Treatment Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?